Inventor · disambiguated record
Kevin Jon Williams
Also filed as: WILLIAMS KEVIN J · WILLIAMS KEVIN JON
16 granted patents·14 pending applications·411 citations·filing 1996–2017
95Inventor score
Files withW2 HOLDINGS INC4WILLIAMS KEVIN J4ESPERION LUV DEV INC3TALARIA THERAPEUTICS INC3UNIV COLUMBIA3
Top patents by PatentIndex Score
30 records- 0190US5843474AMethod of dialysis treatment, and dialysis apparatus related theretoREVERSE TRANSPORT LICENSING &·Filed 1996·Granted Dec 1, 1998·71 cites·49 claims
- 0287US6613322B2Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinaseUNIV COLUMBIA·Filed 2000·Granted Sep 2, 2003·31 cites·5 claims
- 0385US6773719B2Liposomal compositions, and methods of using liposomal compositions to treat dislipidemiasESPERION LUV DEV INC·Filed 2001·Granted Aug 10, 2004·19 cites·12 claims
- 0484US5746223AMethod of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasisFiled 1996·Granted May 5, 1998·52 cites·20 claims
- 0582US5989803AMethod for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinaseUNIV COLUMBIA·Filed 1997·Granted Nov 23, 1999·50 cites·8 claims
- 0680US6399358B1Human gene encoding human chondroitin 6-sulfotransferaseUNIV JEFFERSON·Filed 1998·Granted Jun 4, 2002·50 cites·11 claims
- 0780US5858400AMethod of suppressing a rise in LDL concentrations after administration of an agent having small acceptorsTALARIA THERAPEUTICS INC·Filed 1996·Granted Jan 12, 1999·30 cites·14 claims
- 0874US5736157AMethod of regulating cholesterol related genes, enzymes and other compounds, and pharmaceutical compositionsFiled 1996·Granted Apr 7, 1998·21 cites·43 claims
- 0971US6080422AMethods of angioplasty and cardiac catheterizationTALARIA THERAPEUTICS INC·Filed 1996·Granted Jun 27, 2000·17 cites·29 claims
- 1070US6079416AMethod of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasisFiled 1998·Granted Jun 27, 2000·24 cites·22 claims
- 1169US8097283B2Methods and compositions for imagingFISHER EDWARD A·Filed 2005·Granted Jan 17, 2012·11 cites·58 claims
- 1267US6367479B1Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related theretoESPERION LUV DEV INC·Filed 1998·Granted Apr 9, 2002·24 cites·15 claims
- 1361US8415107B2Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancerWILLIAMS KEVIN J·Filed 2009·Granted Apr 9, 2013·0 cites·41 claims
- 1461US5948435AMethods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition thereforTALARIA THERAPEUTICS INC·Filed 1997·Granted Sep 7, 1999·10 cites·29 claims
- 1559US2014051098A1Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding AgentsW2 HOLDINGS INC·Filed 2013·Application pending·0 cites
- 1656US7655411B2Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancerW2 HOLDINGS INC·Filed 2003·Granted Feb 2, 2010·1 cites·12 claims
- 1756US2012276559A1Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding AgentsWILLIAMS KEVIN J·Filed 2011·Application pending·0 cites
- 1856US2012271124A1Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding AgentsWILLIAMS KEVIN J·Filed 2011·Application pending·0 cites
- 1953US2011065206A1Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding AgentsW2 HOLDINGS INC·Filed 2010·Application pending·0 cites
- 2051US2004047851A1Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinaseUNIV COLUMBIA·Filed 2003·Application pending·0 cites
- 2150US8053196B2Clinical assays for thrombospondin fragments in the detection, diagnosis, and evaluation of cancerW2 HOLDINGS INC·Filed 2004·Granted Nov 8, 2011·0 cites·104 claims
- 2249US2006257947A1Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agentsWILLIAMS KEVIN J·Filed 2003·Application pending·0 cites
- 2346US2002022053A1Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related theretoFiled 2001·Application pending·0 cites
- 2446US2019224124A1Methods and Kits for Reducing the Susceptibility of Lipoprotein Particles to Atherogenic Aggregation Induced by Arterial-Wall EnzymesWILLIAMS KEVIN JON·Filed 2017·Application pending·0 cites
- 2542US2002071862A1Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions, and kit related theretoESPERION LUV DEV INC·Filed 2002·Application pending·0 cites
- 2641US2004224011A1Liposomal compositions and methods of using the same to treat dyslipidemiasUNIV BRITISH COLUMBIA·Filed 2004·Application pending·0 cites
- 2739US2003170643A1Regulation of apoB treatment and drug screening for cardiovascular and metabolic disorders or syndromesFiled 2002·Application pending·0 cites
- 2832US2002041894A1Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis and pharmaceutical compositions and kit related theretoFiled 1998·Application pending·0 cites
- 2932US2001009670A1Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related theretoFiled 1998·Application pending·0 cites
- 3032US2002064553A1Large liposome composition not increasing ldl levels and method of treating atherosclerosis related theretoFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Jon Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →